Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677

NCT00694902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GSK610677
DRUG: Placebo

Sponsor

GlaxoSmithKline